Trial of Precision Medicine in Emergency Departments
University of Florida · with National Human Genome Research Institute (NHGRI) · NCT06448091
Opens the official ClinicalTrials.gov record, with the study team’s contacts. Bored Studies doesn’t enroll anyone.
Key facts
- Compensation
- Not posted. Ask the study team before screening.
- Who can join
- Ages 40+ · All sexes
- Healthy volunteers
- Accepted
- Study type
- Interventional · Not applicable
- Target enrollment
- 1200
- US sites recruiting
- 2
- Study start
- March 18, 2025
- Record last updated
- June 10, 2026
Status re-checked against ClinicalTrials.gov within the last 12 hours.
What the study is about
The objectives of this study are to (1) test the feasibility of the clinical implementation of preemptive pharmacogenetic (PGx) testing in the emergency department (ED) and (2) determine if PGx testing (with appropriate decision support) decreases ED return visits and hospitalizations. We will conduct a randomized, controlled, pragmatic clinical trial assessing both the real-world effectiveness as well as implementation outcomes using a targeted PGx testing panel in several UF Health EDs.
Being studied: Panel-based pharmacogenetic genotyping
Conditions: Pharmacogenomic Drug Interaction
Eligibility criteria
Copied from the official record. The study team makes the final decision at screening.
Show full criteria
Inclusion Criteria
- Adults 40 years or older presenting to a participating ED
- Receipt of a new order/prescription for a selected PGx medication (Appendix 1), with a duration greater than 7 days, during the current ED visit or within 30 days prior.
- Documentation of at least 2 prior ED or urgent care visits within the past 12 months
Exclusion Criteria
- Prior clinical pharmacogenetic test results within the EHR for genes relevant for this study (Appendix 1).
- History of hepatic or renal transplant
- History of severe liver disease (stage Child-Pugh C) or renal disease eGFR \<15 ml/min.
- Any medical condition that would prohibit the ability to complete the study
- Prisoners, wards of the state, or patients being held under the Baker Act or Marchman Act
- Life expectancy less than 6 months
Recruiting US locations
UF Health Jacksonville Downtown Emergency Department
Jacksonville, FL 32209
Site contact: Morgan Henson, MPH · 904-244-4234 · morgan.henson@jax.ufl.edu
UF Health Jacksonville North Emergency Department
Jacksonville, FL 32218
Site contact: Morgan Henson, MPH · 904-244-4234 · morgan.henson@jax.ufl.edu
Study contacts (from the official record)
- Erica N Elwood, MHA · 3522736007 · erica.elwood@cop.ufl.edu
Similar studies in Florida
All healthy volunteers studies in Florida →- RecruitingHealthy volunteersPhase 1Overnight stay mentioned
A Study of LY4302814 in Healthy Participants
Eli Lilly and Company
- Location
- Daytona Beach, FL
- Eligibility basics
- Ages 18–65
- RecruitingHealthy volunteersPhase 1Overnight stay mentioned
A Study to Learn How the Body Processes the Study Medicine PF-07328948 in People With Reduced Kidney Function
Pfizer
- Location
- Orlando, FL + 3 other US sites
- Eligibility basics
- Ages 18–80
- RecruitingHealthy volunteersPhase 1Overnight stay mentioned
Safety and PK Study of BICX104 With or Without Bupropion Compared to Vivitrol
BioCorRx Pharmaceuticals Inc
- Location
- Miami, FL
- Eligibility basics
- Ages 18–65
- RecruitingHealthy volunteersPhase 1
Ph 1a/1b Single Ascending Dose and Multiple Ascending Dose Study of ARQ-234
Arcutis Biotherapeutics, Inc.
- Location
- Miami, FL + 6 other US sites
- Eligibility basics
- Ages 18–65